Farmers & Merchants Investments Inc’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-41	Closed	-$4.67K	–	1816
2022 Q4	$4.67K	Buy	+41	New	+$3.4K	﹤0.01%	775
2022 Q3	–	Sell	-441	Closed	-$35K	–	1825
2022 Q2	$35K	Buy	441 +21	+5%	+$1.99K	﹤0.01%	473
2022 Q1	$44K	Buy	420 +15	+4%	+$1.46K	﹤0.01%	442
2021 Q4	$44K	Hold	405	–	–	﹤0.01%	443
2021 Q3	$44K	Buy	405 +24	+6%	+$2.49K	﹤0.01%	423
2021 Q2	$36K	Buy	381 +57	+18%	+$5.25K	﹤0.01%	401
2021 Q1	$30K	Buy	324 +21	+7%	+$1.77K	﹤0.01%	400
2020 Q4	$22K	Buy	303 +18	+6%	+$1.34K	﹤0.01%	445
2020 Q3	$22K	Sell	285 -66	-19%	-$4.54K	﹤0.01%	421
2020 Q2	$20K	Buy	+351	New	+$15K	﹤0.01%	428
2019 Q2	–	Sell	-343	Closed	-$9K	–	876
2019 Q1	$9K	Hold	343	–	–	﹤0.01%	579
2018 Q4	$7K	Sell	343 -83	-19%	-$1.63K	﹤0.01%	581
2018 Q3	$8K	Buy	+426	New	+$8.1K	﹤0.01%	615

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Farmers & Merchants Investments Inc's HZNP Position: Q1 2023 in Review

Farmers & Merchants Investments Inc sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 41 shares — an estimated $4.67K sold.

Farmers & Merchants Investments Inc first reported a position in HZNP in Q3 2018 and held it in 13 quarters. The position peaked at $44K in Q1 2022. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Farmers & Merchants Investments Inc reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Farmers & Merchants Investments Inc sold 41 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $4.67K.
Farmers & Merchants Investments Inc first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2018 and held it in 13 quarters.
Farmers & Merchants Investments Inc's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $44K in Q1 2022.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Farmers & Merchants Investments Inc's 13F filing for Q1 2023, filed 12 May 2023.